Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06769490

Phase 1, Recruiting

New Assessment System in Measuring Symptom Distress in Cancer Patients

for
Caregiver, Health Care Provider, Malignant Neoplasm, Physician
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00505245

Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: Houston TX, Kansas City KS, St Louis MO, Orlando FL,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase 3, Recruiting

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05674396

Phase 2, Recruiting

AERA Pediatrics Registry

for
Dysfunction of Eustachian Tube
Location: Houston TX, Fort Worth TX, Cincinnati OH,
Sponsor: Integra LifeSciences Corporation

Sex: All

Age: 0 - 18

Code: NCT07071298

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

for
Hormone-receptor-positive Breast Cancer,
Location: Houston TX, Iowa City IA, Seattle WA
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06756932

Phase 1, Recruiting

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Houston TX, Birmingham AL, Atlanta GA, Tampa FL,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05143996

Phase 1, Phase 2, Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

for
Metastatic Non-small Cell Lung Cancer
Location: Houston TX, Nashville TN, Tampa FL, Baltimore MD,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04410796

Phase 2, Recruiting

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

for
Biochemically Recurrent Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT05054296

Phase 2, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Houston TX, Birmingham AL, Westwood KS, Miami FL,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase 2, Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: Houston TX, Nashville TN, Atlanta GA, Chicago IL,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase 2, Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Houston TX, Oklahoma City OK, Huntersville NC,
Sponsor: Qurgen Inc.

Sex: All

Age: 18+

Code: NCT05989724

Phase 1, Recruiting

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

for
Lung Carcinoma, Malignant Respiratory Tract Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03422302

Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Kingwood TX, Huntsville TX, Austin TX, Harlingen TX,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06760754

Recruiting

Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology

for
Microbial Colonization, Burns
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18 - 70+

Code: NCT05275335

Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Houston TX, Palestine TX, Austin TX, Longview TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

for
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
Location: Houston TX, Smyrna GA, Snellville GA, Jacksonville FL,
Sponsor: Coologics, Inc

Sex: Female

Age: 22 - 49

Code: NCT06983041

Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Houston TX, San Antonio TX, Dallas TX, Denver CO,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase 1, Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Houston TX, Aurora CO, Chicago IL, Miami FL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase 1, Phase 2, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City